Creating accessible care options for patients—from their own homes.
PRA’s Mobile Health Platform (MHP) engages with patients wherever they are. Our app-based platform allows us to do everything that’s possible in a physician’s office or clinical site, virtually.
The same way you bank, sign documents, email, and text on your phone—we can do all of that within a mobile environment for your trial.
Download our Mobile Health Platform fact sheet to learn more
Enhancing collaboration between all study stakeholders.
Our multi-language, multi country platform is designed with patients at the center—but we know that clinical breakthroughs would not be possible without seamless interaction between all stakeholders. Our fit-for-purpose solution provides access to data in real-time, speeding up the decision-making process and helping us get safe and effective treatments to patients faster than ever before.
Download our fact sheet to learn moreMobile solutions to meet your unique needs.
Today, we have the ability to educate patients, gather electronic informed consent and e-signatures, and complete patient reported outcomes—right from the patient’s phone. Using connected devices, we can collect home healthcare data in the same mobile app and serve all of that data into the source for the clinical trial.
Our digital health solutions are built with each specific trial in mind. Depending on the disease state, the patient population, and our sponsor’s targets, our experts will help determine what is most applicable to your particular trial. From enrollment and ongoing engagement efforts to consultations and in-depth analysis, we have the tools needed to conduct your hybrid or virtual trial from start to finish.
Read about PRA’s Decentralized Clinical Trial capabilitiesReducing the burden of participation for patients.
The traditional approach to clinical development requires 100% of visits to take place on-site, which places a huge burden on patients. We have the resources to change that.
If we can enable patients to complete 50% to 75% of clinical tasks in their mobile environment before arriving on-site, that site visit might only last an hour instead of five. It may seem small, but those four hours can have a meaningful impact for patients and site staff.
We identify ways to minimize time on-site, often replacing site visits with home healthcare visits and even full virtual visits—while still collecting necessary endpoints in a valid way. By incorporating mobile solutions, we can reduce the burden on patients and provide significant value to our sponsors.
Learn how wearable technologies are eliminating many traditional barriers of clinical trial participation.Explore related content and topics
Blog
COVID-19 Kicks Healthcare Technology Adaptation into High Gear
From telemedicine to decentralized clinical trials to artificial intelligence and beyond, the COVID-19 crisis has kicked the use of technology in the…
Blog
Improving Trial Participation for Families Through Decentralized Clinical Trials
As understanding advances and precedents are established for DCT-focused development programs, all stakeholders in clinical research will benefit…
White Paper
Bridging the Diversity Gap with Decentralized Trials
The current drug development research paradigm is flawed in that it fails to include a diverse and representative patient population. A new approach…